Companies / Santa Cruz Biotechnology / IFN-γ (G-23) HRP
Santa Cruz Biotechnology

IFN-γ (G-23) HRP | Santa Cruz Biotechnology

mouse monoclonal IgG1; IFN-γ/Interferon gamma Antibody (G-23) is an IgG1 κ mouse monoclonal IFN-γ antibody that detects precursor and mature IFN-γ of human origin by WB, IP, IF, FCM and ELISA. IFN-γ/Interferon gamma Antibody (G-23) is available as the non-conjugated anti-IFN-γ antibody form, as well as multiple conjugated forms of anti-IFN-γ antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Interferon (IFN)-γ is an antiviral and antiparasitic agent produced by CD4+/CD8+ lymphocytes and natural killer cells that undergo activation by antigens, mitogens or alloantigens. IFN-γ production modulates T cell growth and differentiation and inhibits the growth of B cells. Synthesis of IFN-γ is inducible by IL-2, FGF and EGF. The active form of IFN-γ is a homodimer with each subunit containing six helices. The dimeric structure of human IFN-γ is stabilized by non-covalent interactions through the interface of the helices. IFN-γ translated precursor is 166 amino acids, including the 23 amino acid secretory sequence. Multiple forms exist due to variable glycosylation and under non-denaturing conditions due to dimers and tetramers.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

  • See More